DIM – a must for hormonally driven tumors
Dr. Kevin Conners – A review of recent literature
Indole-3-carbinol (I3C) is an essential nutrient found in Brassica vegetables, such as broccoli, cauliflower, and collard greens. Diindolylmethane (DIM) is the digestion derivative of indole-3-carbinol via condensation formed in the acidic environment of the stomach. If you are going to use I3C as a nutritional supplement (and you may want to consider this after reading this article), take DIM. DIM has long been studied for its anti-carcinogenic effects and its ability to bind and rid the body of ‘bad’ estrogens. These so-called ‘bad’ estrogens are both made in the body as intermediate metabolites and consumed through estrogen exposure in drinking water and estrogen disruptors such as plastics. The later are termed xenoestrogens, as there are toxins from environmental sources.
DIM’s history for cancer prevention and therapy  began when a mouse study showed its promising results in tobacco smoke, carcinogen-induced, lung adenocarcinoma. DIM was found to have ‘lung cancer preventive effects’ that are mediated via modulation of the receptor tyrosine kinase/PI3K/Akt-signaling pathway . DIM demonstrated ‘exceptional anti-cancer effects against hormone responsive cancers like breast, prostate and ovarian cancers’ . In a recent study, it was concluded that DIM rather than I3C was the active agent in cell culture studies destroying cancer .
DIM transduces signaling via aryl hydrocarbon (Ah) receptor, NF-κB/Wnt/Akt/mTOR pathways, to help inhibit growth. These pathways are typically up regulated in cancer patients yet DIM may help block many of these avenues.
DIM was also found to induce cell cycle arrest, helping slow replication of cancer cells. It also helps modulate key CYP enzymes in the liver, aiding important detoxification channels. DIM was found to alter angiogenesis, the lay-down of new vessels that cancers rely on for continued growth. It decreases cell invasion, metastasis and epigenetic behavior of cancer cells as well .
DIM was found to induce Nrf2-mediated, intercellular detoxification (GSTm2, UGT1A1, and NQO1) and antioxidant (HO-1 and SOD1) genes. These pathways are our essential detoxification pathways inside every cell. Think of them as the cellular garbage service that gets rid of the poisons that would otherwise wreak havoc. Individuals with genetic defects on Nrf2, Glutathione, and SOD genes have an even greater need to support such cellular garbage service.
DIM has also shown synergistic benefits with isothiocyanates, and sulforaphane, the nutrients found in cruciferous vegetables that have been found to have such wonderful benefits for patients with cancer .
Overall, DIM showed anti-cancer properties, especially in hormonally driven tumors. DIM is currently in clinical trials for various other forms of cancers, however, given its benefits to boost other natural therapies, it may be a good add for all cancer patients.
 Kim YS, Milner JA. Targets for indole-3-carbinol in cancer prevention. J Nutr Biochem. 2005;16(2):65–73. [PubMed]
 Qian X, Melkamu T, Upadhyaya P, Kassie F. Indole-3-carbinol inhibited tobacco smoke carcinogen-induced lung adenocarcinoma in A/J mice when administered during the post-initiation or progression phase of lung tumorigenesis. Cancer Lett. 2011 [PMC free article] [PubMed]
 Acharya A, Das I, Singh S, Saha T. Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis. Recent Pat Food Nutr Agric. 2010;2(2):166–177. [PubMed]
 Bradlow HL, Zeligs MA. Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments. In Vivo. 2010;24(4):387–391. [PubMed]
 Banerjee S, Kong D, Wang Z, Bao B, Hillman GG, Sarkar FH. Attenuation of multi-targeted proliferation-linked signaling by 3,3′-diindolylmethane (DIM): From bench to clinic. Mutat Res. 2011[PMC free article] [PubMed]
 Saw CL, Cintron M, Wu TY, Guo Y, Huang Y, Jeong WS, Kong AN. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharm Drug Dispos. 2011;32(5):289–300.[PMC free article] [PubMed]
Dr. Conners graduated with his doctorate from Northwestern Health Sciences University in 1986 and has been studying alternative cancer care for over 20 years. He holds AMA Fellowships in Regenerative & Functional Medicine and Integrative Cancer Therapy.
He is the author of numerous books including, Stop Fighting Cancer and Start Treating the Cause, Cancer Can’t Kill You if You’re Already Dead, Help, My Body is Killing Me, Chronic Lyme, 3 Phases of Lyme, 23 Steps to Freedom, and many more you can download for FREE on our books page.